Compare · ARA vs PGNY
ARA vs PGNY
Side-by-side comparison of American Renal Associates Holdings, Inc (ARA) and Progyny Inc. (PGNY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ARA and PGNY operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- PGNY carries a market cap of $1.42B.
- PGNY has hit the wire 5 times in the past 4 weeks while ARA has been quiet.
- PGNY has more recent analyst coverage (25 ratings vs 0 for ARA).
- Company
- American Renal Associates Holdings, Inc
- Progyny Inc.
- Price
- -
- $18.18+2.89%
- Market cap
- -
- $1.42B
- 1M return
- -
- +2.42%
- 1Y return
- -
- -20.05%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2016
- 2019
- News (4w)
- 0
- 5
- Recent ratings
- 0
- 25
Progyny Inc.
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Latest ARA
- SEC Form 15-12B filed
- SEC Form EFFECT filed
- SEC Form SC 13G/A filed
- SEC Form 4 filed by P L Partners Capital Centerbridge
- SEC Form 4: W Thomas Erickson disposed to the issuer $0 worth of Common Stock (67,755 units at $0.00), decreasing ownership by 100% to 0 units
- SEC Form 4: J Christopher Hocevar disposed to the issuer $0 worth of Common Stock (18,679 units at $0.00), decreasing ownership by 100% to 0 units
- SEC Form 4: A Joseph Carlucci disposed to the issuer $0 worth of Common Stock (1,245,164 units at $0.00), decreasing ownership by 100% to 0 units
- SEC Form 4: M John Jureller disposed to the issuer $0 worth of Common Stock (49,435 units at $0.00), decreasing ownership by 100% to 0 units
- SEC Form 4: T Syed Kamal disposed to the issuer $0 worth of Common Stock (1,291,236 units at $0.00), decreasing ownership by 100% to 0 units
- SEC Form 4: Victoria Labriola disposed to the issuer $0 worth of Common Stock (64,569 units at $0.00), decreasing ownership by 100% to 0 units
Latest PGNY
- Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report
- SEC Form 4 filed by Cummings Melissa B
- Progyny Expands Access to Fertility and Women's Health with Industry's First Fully Insured Supplemental Plan
- SEC Form DEFA14A filed by Progyny Inc.
- SEC Form DEF 14A filed by Progyny Inc.
- Progyny Commemorates 10 Years of Redefining Women's Health and Family Building Care
- SEC Form PRE 14A filed by Progyny Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Progyny Inc.
- SEC Form 4 filed by Clapp Geoffrey
- Progyny Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits